IPAZIQ

Pharmaceutical preparations for treatment of cancerous cells and tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immuno-suppressive cells; therapeutic agents for use in combination with cancer therapies such as immune checkpoint inhibitors, hormone therapies and chemotherapies